In this phase 3 trial, researchers aimed to assess morbidity and efficacy of 3-week hypofractionated locoregional radiotherapy compared to 5-week radiotherapy.

Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers The Iowa Women's Health Study (IWHS) collected ...

VEGF-inducing gene therapy did not significantly improve outcomes with vascularized lymph node transfer for lymphedema. Arm volume reduction and quality of life were similar between treatment groups.

Choosing the right seat can help protect the arm and allow for periodic elevation without disturbing others. Compression sleeves should be in optimal condition; elasticity can degrade over time, ...

PITTSBURGH — It’s estimated that 10 million people in the U.S. suffer from lymphedema. The painful build-up of fluid has several causes, but fewer solutions. Katherine Amenta sat down exclusively with ...

The call to integrate prospective surveillance for lymphedema into cancer care pathways is building momentum to enable early intervention and prevent the progression of the condition. We offer a ...

HARTFORD, Conn. (WTNH) — Arm lymphedema is a common and sometimes challenging side effect that can occur after breast cancer treatment, causing swelling, discomfort, and limitations in daily ...

CARLSBAD, Calif., Feb. 15, 2024 /PRNewswire/ -- ImpediMed, a pioneer in the field of medical technology, announced a significant advancement in the fight against breast cancer-related lymphedema, a ...